Table . Suggested Statements Clustered and Ranked Based on Importance and Feasibility for Each Cluster .
| Clusters | Statements in Each Cluster (Statement ID) | Importance | Feasibility |
| Planning | Developing a national ICC prevention guideline and defining appropriate screening test, starting age and interval for regular screenings (1) | 8.4 | 6.6 |
| Developing protocols for screening process and follow-up of the patients with precancerous lesions (2) | 7.5 | 5.2 | |
| Implementation of screening programs | Using an electronic registration system for screening data (8) | 8.6 | 5.9 |
| Coverage of cervical screening by insurance companies (4) | 8.4 | 6.9 | |
| Providing necessary equipment and resources to laboratories for screening test (kits, instruments, personnel, and etc.) (7) | 8.5 | 4.8 | |
| Engagement of family physicians and healthcare system in cervical screening (5) | 8.2 | 4.8 | |
| Elimination of legal boundaries and implementing an organize cervical screening by MoHME (3) | 9.0 | 4.1 | |
| Using appropriate screening strategy to increase the participation rate in the screening program (6) | 7.9 | 4.1 | |
| Quality control program | Developing quality control protocols for the process of patient follow-up (ie, management of precancerous lesions and the treatment of cancer patients) (11) | 8.6 | 6.5 |
| Developing quality assurance protocols for laboratories that are involved in the screening program (9) | 8.7 | 5.3 | |
| Developing quality assurance protocols for management of the screening program in terms of accuracy and coverage (10) | 4.4 | 4.6 | |
| Research | Evaluating the role of partners/husbands in participation of women in cervical screening (18) | 8.5 | 5.8 |
| Conducting cost-effectiveness study for HPV vaccination in Iran (12) | 8.1 | 5.7 | |
| Regular monitoring of the incidence and prevalence of precancerous lesions (20) | 7.7 | 5.9 | |
| Evaluation of benefits and requirement for using Liquid Base Cytology technique for cervical screening test (15) | 7.3 | 7.0 | |
| Identifying the incentives and barriers for participation in cervical cancer screening in the country (14) | 7.3 | 6.2 | |
| Nationwide study of survival rate and prognostic factors for cervical cancer (22) | 7.7 | 5.3 | |
| Determining the risk factors of cervical cancer specially determining variations in high risk behaviors associated with the incidence of cervical cancer among young people (13) | 7.2 | 6.1 | |
| Identifying the knowledge, attitude, and practice of target group women and healthcare providers about cervical cancer screening programs (16) | 7.6 | 5.0 | |
| Determining the prevalence of HPV infection and precancerous lesions among high-risk groups (17) | 7.1 | 5.0 | |
| Conducting a demonstration project for organized screening program in a selected province (24) | 8.1 | 3.8 | |
| Accurate assessment of the incidence, prevalence and mortality of cervical cancer (23) | 6.5 | 4.4 | |
| Evaluation of sero-epidemiology of HPV infection in general population (21) | 6.6 | 3.9 | |
| Research on epidemiology of genital warts (19) | 6.2 | 5.4 | |
| Health promotion and training | Increasing public awareness about cervical cancer screening through mass media (Internet, TV, radio, newspapers, etc.) (26) | 8.1 | 6.2 |
| Training of clinicians and other healthcare providers about cervical screening programs (25) | 7.6 | 6.2 |
Abbreviations: ICC, invasive cervical cancer; MoHME, Ministry of Health and Medical Education; HPV, human papilloma virus.